Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
D000941:Antigens / Q000737:chemistry; D000951:Antigens, Neoplasm / Q000737:chemistry* / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism; D002460:Cell Line; D045744:Cell Line, Tumor; D016207:Cytokines / Q000096:biosynthesis; D018076:DNA, Complementary / Q000378:metabolism; D003713:Dendritic Cells / Q000166:cytology; D000939:Epitopes; D015234:HLA-A Antigens / Q000737:chemistry* / Q000378:metabolism; D059871:HLA-A24 Antigen; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism*; D009369:Neoplasms / Q000628:therapy*; D010455:Peptides / Q000737:chemistry; D011485:Protein Binding; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013602:T-Lymphocytes, Cytotoxic / Q000737:chemistry* / Q000378:metabolism
D000941:Antigens; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; C104948:CTAG1B protein, human; D016207:Cytokines; D018076:DNA, Complementary; D000939:Epitopes; D015234:HLA-A Antigens; D059871:HLA-A24 Antigen; D008565:Membrane Proteins; D010455:Peptides